CANNARA BIOTECH INC (LOVE.CA) Stock News

Canada - TSX-V:LOVE - CA13765U2002 - Common Stock

1.75 CAD

+0.02 (+1.16%)

Last: 9/17/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

LOVE.CA Latest News, Press Relases and Analysis

All

Press Releases

17 days ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce l’octroi d’options d’achat d’actions et d’unités d’actions restreintes (RSU)

17 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Grant of Options and RSUs

17 days ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Grant of Options and RSUs

a month ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce la modification et l’augmentation de la facilité de crédit accordée par BMO afin de soutenir l’expansion de ses installations à Valleyfield

a month ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

a month ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

a month ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech renforce sa flexibilité financière grâce à la vente stratégique d'actifs

a month ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

a month ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech enregistre son chiffre d’affaires et sa rentabilité les plus élevés depuis sa création au troisième trimestre de l’exercice 2025

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

2 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara obtient 5 inscriptions clés dans la nouvelle catégorie de cartouches de vapotage de la SQDC, y compris des cartouches de vapotage à base de rosine vivante à venir

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes

2 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers du troisième trimestre de l'exercice 2025 le 28 juillet 2025

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

2 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech organise une webdiffusion pour les investisseurs le 25 juin 2025

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech to Host Investor Webcast on June 25th, 2025

3 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech to Host Investor Webcast on June 25th, 2025

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara réduit le coût de sa dette en abaissant son taux d’intérêt et en remboursant partiellement sa débenture convertible ; remporte le prix de la marque de l’année 2025

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech affiche des résultats record au deuxième trimestre et accélère son expansion nationale

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

5 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

3 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers pour le deuxième trimestre de l'exercice 2025 le 28 avril 2025

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

5 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

6 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech annonce la nomination de Justin Cohen au conseil d’administration

6 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors

6 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech fera une présentation à la Ventum Canadian Cannabis Conference le 12 mars 2025

7 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

8 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech annonce des produits et une part de marché nationale records pour le premier trimestre 2025, ouvrant la voie à un élan continu en 2025

8 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

7 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy

8 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025